Form 4: Retractable Technologies CEO Boosts Stake

Retractable Technologies Inc. President and CEO Thomas J. Shaw acquired additional common stock shares through pre-planned transactions.

Summary

• Thomas J. Shaw, President and CEO, Director, and 10% Owner of Retractable Technologies Inc. (RVP), acquired additional shares of common stock.
• On August 14, 2025, Mr. Shaw purchased 3,103 shares of common stock at a weighted average price of $0.7875 per share.
• On August 15, 2025, Mr. Shaw purchased an additional 10,980 shares of common stock at a weighted average price of $0.7948 per share.
• These transactions were made pursuant to a Rule 10b5-1 plan, which was adopted on August 22, 2024.
• Following these acquisitions, Mr. Shaw directly beneficially owns 15,603,348 shares of common stock.
• Additionally, Mr. Shaw indirectly controls 831,600 shares, including 500,000 shares as Trustee for a family member and the remainder via a voting agreement.

Sentiment

Score: 7

Explanation: The sentiment is positive due to insider buying by the CEO and a significant owner, indicating confidence. The transactions were pre-planned, which adds a layer of systematic investment rather than opportunistic timing. The amount, while not massive, adds to existing substantial holdings.

Positives

• The President and CEO, Thomas J. Shaw, increased his direct beneficial ownership in the company, signaling confidence in future prospects.
• The acquisitions were made through a pre-arranged Rule 10b5-1 plan, indicating a systematic approach to increasing stake rather than opportunistic timing.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance beyond the execution of pre-planned stock acquisitions.

Industry Context

Insider buying, particularly by a CEO and significant owner, can be interpreted as a positive signal of management's belief in the company's future performance within its industry, which for Retractable Technologies Inc. is the medical device sector, specifically safety syringes and needles.

Comparison to Industry Standards

• Insider buying activity, especially by top executives, is generally viewed favorably across all industries as it indicates management's confidence in the company's valuation and future prospects.
• While the total number of shares acquired (14,083) is not exceptionally large compared to the CEO's existing substantial holdings (over 15 million shares), it represents a continued commitment to increasing personal stake.
• Compared to other medical device companies, consistent insider buying, even in smaller increments, can differentiate a company by demonstrating strong internal conviction in its product pipeline or market position.

Related Party Transactions

• Thomas J. Shaw, as a reporting person, is a related party to Retractable Technologies Inc. The transactions involve his acquisition of company stock.

Stakeholder Impact

• Shareholders may view the CEO's increased stake as a positive indicator of management's belief in the company's value, potentially boosting investor confidence.
• Employees might perceive this as a sign of stability and positive outlook from leadership.

Key Dates

Recommendation

The acquisition of shares by the President and CEO, who is also a significant owner, signals strong insider confidence in Retractable Technologies Inc.'s future. While the individual transaction amounts are modest, they contribute to an already substantial holding and were executed under a pre-planned Rule 10b5-1 program, suggesting a deliberate long-term investment strategy. This insider buying activity, especially from a key executive, often precedes positive company developments or reflects a belief that the stock is undervalued, making it a 'buy' signal for seasoned investors.

Keywords

Retractable Technologies, RVP, Insider Buying, SEC Form 4, Thomas J. Shaw, CEO, Stock Acquisition, 10b5-1 Plan, Medical Devices, Healthcare